NEW YORK, July 23. 10, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds buyers of Outset Medical, Inc. (NASDAQ: OM) securities between Sept. 15, 2020 and June 13, 2022, both dates inclusive (the “Class Period”), of the important deadline of September 6, 2022 for lead plaintiff.
AND SO: If you purchased Outset Medical securities during the Class Period, you may be entitled to compensation without payment of disbursements or fees through a contingency fee arrangement.
WHAT TO DO NEXT: To join the Outset Medical class action lawsuit, go to https://rosenlegal.com/submit-form/?case_id=6976 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for class action information. A class action lawsuit has already been filed. If you wish to act as a lead plaintiff, you must move the Court no later than September 6, 2022. A lead plaintiff is a representative party acting on behalf of other class members to direct litigation.
WHY ROSEN LAW: We encourage investors to select qualified lawyers with proven track records in leadership roles. Often, companies issuing reviews do not have comparable experience, resources, or significant peer recognition. Many of these firms do not actually handle securities class action lawsuits, but are merely middlemen who refer clients or partner with law firms that actually litigate the cases. Be wise in choosing lawyers. Rosen Law Firm represents investors worldwide, focusing its practice on securities class action and shareholder derivative litigation. Rosen Law Firm has reached the largest securities class action settlement against a Chinese company. Rosen Law Firm was ranked #1 by ISS Securities Class Action Services for the number of securities class action settlements in 2017. The firm has ranked in the top 4 every year since 2013 and has recovered hundreds of million dollars for investors. In 2019 alone, the company secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s lawyers have been recognized by Lawdragon and Super Lawyers.
CASE DETAILS: According to the lawsuit, Defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) Defendants had “continually made improvements and updates to Tablo over time since its initial authorization” which required an additional 510(k) application; (2) as a result, Outset Medical was unable to conduct a human factors study on a device cleared under FDA protocols; (3) Outset Medical’s inability to conduct the human factors study subjected Outset Medical to the likelihood that the FDA would impose a “suspension of shipment” and marketing suspension, leaving the company unable to sell Tablo for home use; and (4) therefore, defendants’ positive statements about Outset Medical’s business, operations and prospects were materially false and misleading and/or lacked reasonable basis at all relevant times. When the real details entered the market, the lawsuit claims investors suffered damages.
To join the Outset Medical class action lawsuit, go to https://rosenlegal.com/submit-form/?case_id=6976 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for class action information.
No class has been certified. Until a class is certified, you are not represented by an attorney unless you retain one. You can choose the lawyer of your choice. You can also remain an absent party member and do nothing at this point. An investor’s ability to participate in any potential future upturn does not depend on their status as lead plaintiff.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Lawyer advertisement. Previous results do not guarantee a similar result.
Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, Pennsylvania
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827